In addition to raising its dividend by 34% this morning, Baxter International (BAX +2.9%) also...
Wednesday, July 25, 2012, 12:49 PM ETIn addition to raising its dividend by 34% this morning, Baxter International (BAX +2.9%) also approves a new $2B stock buyback program, as the health-care company looks to share the wealth and boost shareholder value. BAX has benefited recently on strong demand for its hemophilia and immunodeficiency products, and because of its product focus on life-threatening ailments and injuries, the company has been less impacted by the slowdown in health-care spending than its peers.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles